Ketchum William A, Lin-Hurtubise Kevin M, Ochmanek Emily, Ishihara Kelli, Rice Robert D
National Cancer Consortium, Walter Reed National Military Medical Center (WRNMMC), Bethesda, MD (WAK).
Department of Surgery, Tripler Army Medical Center (TAMC), Honolulu, HI (KML-H, KI).
Hawaii J Med Public Health. 2019 Apr;78(4):128-131.
The majority of giant hepatic cavernous hemangiomas are asymptomatic and can safely be observed. However, when a lesion becomes symptomatic, affecting quality of life or cannot be distinguished from a malignancy, then operative therapy should be considered. We herein present a case of a symptomatic 12cm × 14cm × 17cm "mega" hemangioma (>10cm) of the left hepatic lobe. This lesion was initially refractory to transarterial embolization of the left hepatic artery, but was subsequently treated successfully with a left lateral extended hepatic segmentectomy (resection). We thus advocate a rational treatment algorithm for management of hepatic "mega" hemangiomas.
大多数巨大肝海绵状血管瘤无症状，可安全观察。然而，当病变出现症状、影响生活质量或无法与恶性肿瘤区分时，则应考虑手术治疗。我们在此报告一例左肝叶有症状的12cm×14cm×17cm“巨型”血管瘤（>10cm）。该病变最初对左肝动脉经动脉栓塞治疗无效，但随后通过左肝外侧叶扩大切除术（切除）成功治疗。因此，我们提倡一种合理的肝“巨型”血管瘤治疗方案。
